MEDPLUS Medplus Health Services Q1 FY27 results (Apr–Jun 2026) and concall
MedPlus Health Services reported a robust 21.8% Y-o-Y growth in pharmacy operations revenue for Q1 FY27, with consolidated revenue reaching INR18,796 million. However, operating EBITDA margin compressed to 3.5%, partly due to a contraction in private label share and increased employee costs. The company has paused its diversification capex plans and is addressing challenges in its franchisee model, while maintaining its target of 800 net new store additions for FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 21.2%, net profit up 21.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 156 | 177 | 202 | 184 | 206 +32% | 223 +26% | 248 +23% | 223 +21% |
| EBITDA | 17 | 19 | 24 | 24 | 27 +59% | 29 +53% | 27 +13% | 29 +21% |
| Net profit | 8 | 9 | 14 | 14 | 16 +100% | 17 +89% | 17 +21% | 17 +21% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
